GainersToday.com
GainersToday.com, Tracking Stock Market Picks
Enter Symbol:
 
Zimmer Holdings, Inc. (ZBH) [hlAlert]

Rating:
Buy ZMH
up 1.38 %

Zimmer Holdings, Inc. (ZMH) upgraded to Buy with price target $133 by Summer Street Research

Posted on: Monday,  May 19, 2014  12:00 AM ET by Summer Street Research

Summer Street Research rated Buy Zimmer Holdings, Inc. (NYSE: ZBH) on 05/19/2014, when the stock price was $102.00.
Since then, Zimmer Holdings, Inc. has gained 1.38% as of 01/12/2016's recent price of $103.41.
If you would have followed this Summer Street Research's recommendation on ZBH, you would have gained 1.38% of your investment in 603 days.

Zimmer Holdings, Inc. (Zimmer) designs, develops, manufactures and markets orthopaedic and dental reconstructive implants, spinal implants, trauma products and related surgical products. The Company also provides other healthcare related services. Its primary customers include musculoskeletal surgeons, neurosurgeons, oral surgeons, dentists, hospitals, stocking distributors, healthcare dealers and, in their capacity as agents, healthcare purchasing organizations or buying groups. These customers range from large multinational enterprises to independent surgeons. It has operations in more than 25 countries and market products in more than 100 countries. In October 2008, the Company acquired Abbott Spine. It markets and sells products through three channels: direct to healthcare institutions, such as hospitals or direct channel accounts; through stocking distributors and, in the Asia Pacific region, healthcare dealers, and directly to dental practices and dental laboratories.

Summer Street Research s is an institutional equity research and trading firm that focuses exclusively on the healthcare sector. Our mission is to help our clients maximize returns by providing the best healthcare research, ideas, and investment opportunities. In recognition of our excellence in research, Summer Street Research Partners was the 2005 winner of Institutional Investor's "Best Independents" award for both biotechnology and specialty pharmaceutical research.
Stock Market Advice
Date/Time (ET)SymbolRatingTermPrice (*)Target
5/19/2014 12:00 AM Buy
None
102.00 133.00
as of 1/1/0001
1 Week   
1 Month   
3 Months   
1 YTD   
Previous Recommendations
Date/Time (ET)SymbolRatingTermPrice (*)Target
1/30/2013 10:25 AM Hold
None
74.73

(*) Stock Price at the time of the recommendation.
RSS Feed | |  Facebook |  Twitter |  Google Plus
Home | Terms of Use | Advertise | FAQ | Support Page | Contact Us | About Us | Privacy Policy